Artificial Intelligence in Medicine: Mitigating Risks and Maximizing Benefits Via Quality Assurance, Quality Control, and Acceptance Testing
Overview
Authors
Affiliations
The adoption of artificial intelligence (AI) tools in medicine poses challenges to existing clinical workflows. This commentary discusses the necessity of context-specific quality assurance (QA), emphasizing the need for robust QA measures with quality control (QC) procedures that encompass (1) acceptance testing (AT) before clinical use, (2) continuous QC monitoring, and (3) adequate user training. The discussion also covers essential components of AT and QA, illustrated with real-world examples. We also highlight what we see as the shared responsibility of manufacturers or vendors, regulators, healthcare systems, medical physicists, and clinicians to enact appropriate testing and oversight to ensure a safe and equitable transformation of medicine through AI.
Jacob C, Brasier N, Laurenzi E, Heuss S, Mougiakakou S, Coltekin A J Med Internet Res. 2025; 27:e67485.
PMID: 39909417 PMC: 11840377. DOI: 10.2196/67485.
Commentary: Technological innovations for improved prevention and diagnosis of oral disease.
Qamar W Front Oral Health. 2025; 5:1505435.
PMID: 39902082 PMC: 11788299. DOI: 10.3389/froh.2024.1505435.
Bridging the gap: Phage manufacturing processes from laboratory to agri-food industry.
Mohammadi E, Rahimian M, Panahi B Virus Res. 2025; 353:199537.
PMID: 39880310 PMC: 11833641. DOI: 10.1016/j.virusres.2025.199537.
Revolutionising oral organoids with artificial intelligence.
Yang J, Fischer N, Ye Z Biomater Transl. 2025; 5(4):372-389.
PMID: 39872928 PMC: 11764189. DOI: 10.12336/biomatertransl.2024.04.004.
Avanzo M, Stancanello J, Pirrone G, Drigo A, Retico A Cancers (Basel). 2024; 16(21).
PMID: 39518140 PMC: 11545079. DOI: 10.3390/cancers16213702.